[1] Bergmann O,Bhardwaj RD,Bernard S,et al. Evidence for Cardiomyocyte renewal in humans.Sicence. 2009;324 (5923):98-102. [2] Wang J,Chen T,JiangJ, et al.Hypoxic preconditioning attenuates hypoxia/reoxygenation-induced apoptosis in mesenchymal stem cells.ActaPharmacol Sin. 2008;29(1): 74-82. [3] Bao C, Guo J, ZhengM,et al. Enhancement of the survival of engrafted mesenchymal stem cells in the ischemic heart by TNFR gene transfection.Biochem Cell Biol. 2010;88(4):629-634. [4] Pons J,Huang Y,Takagawa J, et al. Combining angiogenic gene and stem cell therapies for myocardial infarction.J Gene Med. 2009;11(9):743-753.[5] He Z, Li H, ZuoS,et al.Transduction of Wnt 11 Promotes Mesenchymal Stem Cell Transdifferentiation into Cardiac Phenotypes. Stem Cells Dev. 2011,;20(10):1771-1778. [6] Cho J, Zhai P, Maejima Y,et al. Myocardial Injection With GSK-3 {beta }-Overexpressing Bone Marrow-Derived Mesenchymal Stem Cells Attenuates Cardiac Dysfunction After Myocardial Infarction. Circ Res. 2010;108(4):478-489. [7] Jiang S, Haider H, IdrisNM, et al.Supportive interaction between cell survival signaling and angiocompetent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair. Circ Res. 2006;99(7):776-784.[8] Zhang Y,LiangJL,WangS,et al.Autologous bone marrow stromal cell transplantation with application of granulocyte colony-stimulating factor improve rabbit cardiac performance after acute myocardial infarction.Nan Fang Yi Ke Da Xue Xue Bao. 2007;27(1):43-48. [9] Yu Q, Chen L, You Y, et al. Erythropoietin combined with granulocyte colony stimulating factor enhances MMP-2 expression in mesenchymal stem cells and promotes cell migration. Mol Med Report. 2011;4(1):31-36.[10] Pasha Z, WangY, SheikhR, et al.Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium .Cardiovasc Res. 2008;77(1): 134-142. [11] JawadH,Lyon AR, Harding SE, et al. Myocardial tissue engineering.Br Med Bull. 2008;87:31-47. [12] Jin J,JeongSI,ShinYM,et al. Transplantation of mesenchymal stem cells within a poly (lactide-co-1-caprolactone) scaffold improves cardiac function in a rat myocardial infarction model. European Journal of Heart Failure. 2009;1(2):147-153. [13] Schantz JT, Chim H,Whiteman M. Cell guidance in tissue engineering:SDF-1 mediates site-directed homing of mesenchymal stem cells within three-dimensional polycaprolactonescaffolds.Tissue Eng. 2007;13(11): 2615-2624.[14] Zhong S,Shu S,Wang Z, et al. Enhanced homing of mesenchymal stem cells to the ischemic myocardium by ultrasound-targeted microbubbledestruction.Ultrasonics. 2012;52(2):281-286.[15] Otani K, Yamahara K, Ohnishi S,et al. Nonviral delivery of siRNA into mesenchymal stem cells by a combination of ultrasound and microbubbles.J Control Release. 2009; 133(2):146-153. [16] Wolf D, Reinhard A, Krause U, et al. Stem cell therapy improves myocardial perfusion and cardiac synchronicity: new application for echocardiography. J Am SocEchocardiogr. 2007;20(5):512-520.[17] Herbots LD, hooge J,Eroglu E, et al.Improved regional function after autologous bone marrow-derived stem cell transfer in patients with acute myocardial infarction: a randomized, double-blind strain rate imaging study.Eur Heart J. 2009;30(6):662-670.[18] Das H ,George JC, Joseph M , et al. Stem Cell therapy with over expressed VEGF and PDGF genes improves cardiac function in a rat infarct model. PLoS One. 2009;4(10):e7325.[19] Grauss RW, van Tuyn J, Steendijk P, et al. Forced myocardin expression enhances the therapeutic effect of human mesenchymal stem cells after transplantation in ischemic mouse hearts. Stem Cells. 2008;26(4):1083-1093.[20] Amado LC, Schuleri KH, Saliaris AP, et al. Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy. J Am Coll Cardiol,2006,48(10):2116-2124. |